A Case of Lurasidone-Induced Urinary Retention

Shixie Jiang, MD; Rojan Varghese, MD; Alexis Cohen-Oram, MD; Richard Czuma, MD

Prim Care Companion CNS Disord 2022;24(6):21cr03220

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (8)

Yoon PD, Chalasani V, Woo HH. Systematic review and meta-analysis on management of acute urinary retention. Prostate Cancer Prostatic Dis. 2015;18(4):297–302. PubMed CrossRef
Yoshimura N, Chancellor MB. Neurophysiology of lower urinary tract function and dysfunction. Rev Urol. 2003;5(suppl 8):S3–S10. PubMed
Trinchieri M, Perletti G, Magri V, et al. Urinary side effects of psychotropic drugs: A systematic review and metanalysis. Neurourol Urodyn. 2021;40(6):1333–1348. PubMed CrossRef
Faure Walker N, Brinchmann K, Batura D. Linking the evidence between urinary retention and antipsychotic or antidepressant drugs: a systematic review. Neurourol Urodyn. 2016;35(8):866–874. PubMed CrossRef
Kahn B, Boazak M, Ragazino J, et al. An additive mix? acute urinary retention in a patient with benign prostatic hyperplasia treated with suboxone, lurasidone, and trazodone. Focus Am Psychiatr Publ. 2018;16(3):292–298. PubMed CrossRef
Verhamme KMC, Sturkenboom MCJM, Ch Stricker BH, et al. Drug-Induced Urinary Retention Incidence. Management and Prevention; 2008:31.
Riva MA. An update of the preclinical profile of lurasidone. Evidence-Based Psychiatric Care. 2015;1:67–72.
Norouzi-Javidan A, Javanbakht J, Barati F, et al. Effect of 5-HT7 receptor agonist, LP-211, on micturition following spinal cord injury in male rats. Am J Transl Res. 2016;8(6):2525–2533. PubMed